BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7591203)

  • 1. Expression of resistance-related proteins in nephroblastoma after chemotherapy.
    Volm M; Mattern J; Stammler G; Royer-Pokora B; Schneider S; Weirich A; Ludwig R
    Int J Cancer; 1995 Oct; 63(2):193-7. PubMed ID: 7591203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single doses of irradiation on the expression of resistance-related proteins in murine NIH 3T3 and human lung carcinoma cells.
    Stammler G; Pommerenke EW; Mattern J; Volm M
    Carcinogenesis; 1995 Sep; 16(9):2051-5. PubMed ID: 7554053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
    Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin.
    Masanek U; Stammler G; Volm M
    Anticancer Drugs; 1997 Feb; 8(2):189-98. PubMed ID: 9073315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the lung resistance-related protein/major vault protein in the histological compartments of nephroblastomas.
    Efferth T; Bode ME; Schulten HG; Thelen P; Granzen B; Beniers AJ; Mertens R; Gefeller O; Ringert RH; Jakse G; Fuzesi L
    Int J Oncol; 2001 Jul; 19(1):163-8. PubMed ID: 11408938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cells.
    Ishikawa H; Kawano MM; Okada K; Tanaka H; Tanabe O; Sakai A; Asaoku H; Iwato K; Nobuyoshi M; Kuramoto A
    Br J Haematol; 1993 Jan; 83(1):68-74. PubMed ID: 8094626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.
    Kim WJ; Kakehi Y; Kinoshita H; Arao S; Fukumoto M; Yoshida O
    J Urol; 1996 Aug; 156(2 Pt 1):506-11. PubMed ID: 8683726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
    Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistance gene expression and progression of astrocytic tumors.
    Tanaka S; Kobayashi I; Oka H; Fujii K; Watanabe T; Nagashima T; Hori T
    Brain Tumor Pathol; 2001; 18(2):131-7. PubMed ID: 11908869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance.
    Yu DS; Ma CP; Chang SY
    Urol Res; 2000 Apr; 28(2):86-92. PubMed ID: 10850629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.
    Galimberti S; Nagy B; Benedetti E; Pacini S; Brizzi S; Caracciolo F; Papineschi F; Ciabatti E; Guerrini F; Fazzi R; Canestraro M; Petrini M
    Leuk Lymphoma; 2007 Aug; 48(8):1502-9. PubMed ID: 17701580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia.
    Stammler G; Sauerbrey A; Volm M
    Cancer Lett; 1995 Feb; 89(1):129-35. PubMed ID: 7882295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas.
    Efferth T; Schulten HG; Thelen P; Bode ME; Beniers AJ; Granzen B; Ringert RH; Mertens R; Gefeller O; Jakse G; Fuzesi L
    Anticancer Res; 2001; 21(4B):2915-20. PubMed ID: 11712786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
    Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
    Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of gastric cancer cells to chemotherapy drugs in elderly patients and its correlation with cyclooxygenase-2 expression.
    Qiu ZQ; Qiu ZR
    Asian Pac J Cancer Prev; 2015; 16(8):3447-50. PubMed ID: 25921160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance mechanisms in chronic lymphocytic leukemia.
    Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
    Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.